IBDEI0BE ; ; 01-AUG-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.4)
;;=^IBE(358.4,
;;^UTILITY(U,$J,358.4,0)
;;=IMP/EXP SELECTION GROUP^358.4I^1182^1174
;;^UTILITY(U,$J,358.4,1,0)
;;=PHYSICIAN TELEPHONE CODES^1^1
;;^UTILITY(U,$J,358.4,2,0)
;;=NON-PHYSICIAN TELEPHONE CALLS^2^1
;;^UTILITY(U,$J,358.4,3,0)
;;=SEIZURES/EPILEPSY/SPELLS^1^2
;;^UTILITY(U,$J,358.4,4,0)
;;=CEREBROVASCULAR DISEASE^2^2
;;^UTILITY(U,$J,358.4,5,0)
;;=DIZZINESS^3^2
;;^UTILITY(U,$J,358.4,6,0)
;;=ENCEPHALOPATHY^4^2
;;^UTILITY(U,$J,358.4,7,0)
;;=HEADACHE^5^2
;;^UTILITY(U,$J,358.4,8,0)
;;=MOVEMENT DISORDERS^6^2
;;^UTILITY(U,$J,358.4,9,0)
;;=NEOPLASMS^7^2
;;^UTILITY(U,$J,358.4,10,0)
;;=NEURODEGENERATIVE DISEASE^8^2
;;^UTILITY(U,$J,358.4,11,0)
;;=SLEEP DISORDERS^9^2
;;^UTILITY(U,$J,358.4,12,0)
;;=SPECIAL SCREENING^10^2
;;^UTILITY(U,$J,358.4,13,0)
;;=OTHER^11^2
;;^UTILITY(U,$J,358.4,14,0)
;;=BODY MASS INDEX (BMI)^2^3
;;^UTILITY(U,$J,358.4,15,0)
;;=COUNSELING^3^3
;;^UTILITY(U,$J,358.4,16,0)
;;=PREVENTIVE HEALTH ENCOUNTER^1^3
;;^UTILITY(U,$J,358.4,17,0)
;;=HISTORY OF ILLNESS^4^3
;;^UTILITY(U,$J,358.4,18,0)
;;=LONG TERM DRUG USE^5^3
;;^UTILITY(U,$J,358.4,19,0)
;;=OTHER^11^3
;;^UTILITY(U,$J,358.4,20,0)
;;=SCREENING^6^3
;;^UTILITY(U,$J,358.4,21,0)
;;=TRANSPLANT^8^3
;;^UTILITY(U,$J,358.4,22,0)
;;=VACCINATIONS^9^3
;;^UTILITY(U,$J,358.4,23,0)
;;=WOMEN'S HEALTH^10^3
;;^UTILITY(U,$J,358.4,24,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^7^3
;;^UTILITY(U,$J,358.4,25,0)
;;=IMMUNIZATIONS^4^4
;;^UTILITY(U,$J,358.4,26,0)
;;=BEHAVIOR CHANGE INTERVENTION,INDIVIDUAL^1^4
;;^UTILITY(U,$J,358.4,27,0)
;;=COUNSELING RISK FACTOR REDUCTION^2^4
;;^UTILITY(U,$J,358.4,28,0)
;;=OTH PREVENTIVE MEDICINE SERVICES^5^4
;;^UTILITY(U,$J,358.4,29,0)
;;=PREVENTIVE MEDICINE,GROUP^8^4
;;^UTILITY(U,$J,358.4,30,0)
;;=PREVENTIVE HEALTH VISIT-EST PT^6^4
;;^UTILITY(U,$J,358.4,31,0)
;;=PREVENTIVE HEALTH VISIT-NEW PT^7^4
;;^UTILITY(U,$J,358.4,32,0)
;;=IMMUNIZATION ADMINISTRATION^3^4
;;^UTILITY(U,$J,358.4,33,0)
;;=RESPIRATORY^6^5
;;^UTILITY(U,$J,358.4,34,0)
;;=SLEEP TESTING AND EVAL^7^5
;;^UTILITY(U,$J,358.4,35,0)
;;=OXIMETRY^4^5
;;^UTILITY(U,$J,358.4,36,0)
;;=CPAP^1^5
;;^UTILITY(U,$J,358.4,37,0)
;;=EDUCATION/TRAINING^2^5
;;^UTILITY(U,$J,358.4,38,0)
;;=PROLONGED CLINICAL STAFF SERVICES^5^5
;;^UTILITY(U,$J,358.4,39,0)
;;=HOME SLEEP STUDIES^3^5
;;^UTILITY(U,$J,358.4,40,0)
;;=TELEHEALTH PATIENT SITE^8^5
;;^UTILITY(U,$J,358.4,41,0)
;;=WIRELESS MONITOR OF PAP DEVICES^9^5
;;^UTILITY(U,$J,358.4,42,0)
;;=NEW PATIENT^2^6
;;^UTILITY(U,$J,358.4,43,0)
;;=ESTABLISHED PATIENT^1^6
;;^UTILITY(U,$J,358.4,44,0)
;;=CONSULTATIONS^3^6
;;^UTILITY(U,$J,358.4,45,0)
;;=PULMONARY DIAGNOSES^2^7
;;^UTILITY(U,$J,358.4,46,0)
;;=SLEEP DX PRELIMINARY^3^7
;;^UTILITY(U,$J,358.4,47,0)
;;=SLEEP DX CONFIRMED^4^7
;;^UTILITY(U,$J,358.4,48,0)
;;=OTHER SLEEP RELATED DX^6^7
;;^UTILITY(U,$J,358.4,49,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^5^7
;;^UTILITY(U,$J,358.4,50,0)
;;=OBESITY & BMI DX^1^7
;;^UTILITY(U,$J,358.4,51,0)
;;=SPECIAL SERVICES^10^8
;;^UTILITY(U,$J,358.4,52,0)
;;=CHEMO NURSE PROCEDURES^2^8
;;^UTILITY(U,$J,358.4,53,0)
;;=INFUSION DRUGS^7^8
;;^UTILITY(U,$J,358.4,54,0)
;;=BLOOD PRODUCTS^1^8
;;^UTILITY(U,$J,358.4,55,0)
;;=DIAGNOSTIC PROCEDURES^3^8
;;^UTILITY(U,$J,358.4,56,0)
;;=OTHER DRUGS^8^8
;;^UTILITY(U,$J,358.4,57,0)
;;=IMMUNIZATION ADMINISTRATION^5^8
;;^UTILITY(U,$J,358.4,58,0)
;;=IMMUNIZATIONS^6^8
;;^UTILITY(U,$J,358.4,59,0)
;;=PROLONGED SVC-MD/NP/PA^9^8
;;^UTILITY(U,$J,358.4,60,0)
;;=EDUCATION/TRAINING^4^8
;;^UTILITY(U,$J,358.4,61,0)
;;=NEW PATIENT^2^9
;;^UTILITY(U,$J,358.4,62,0)
;;=ESTABLISHED PATIENT^1^9
;;^UTILITY(U,$J,358.4,63,0)
;;=CONSULTATIONS^3^9
;;^UTILITY(U,$J,358.4,64,0)
;;=COMPLEX CHRONIC CARE^4^9
;;^UTILITY(U,$J,358.4,65,0)
;;=ANEMIA^1^10
;;^UTILITY(U,$J,358.4,66,0)
;;=ARTIFICIAL OPENING STATUS^2^10
;;^UTILITY(U,$J,358.4,67,0)
;;=BREASTS and GYN NEOPLASMS^3^10
;;^UTILITY(U,$J,358.4,68,0)
;;=COAGULATION DISORDERS^4^10
;;^UTILITY(U,$J,358.4,69,0)
;;=COUNSELING AND SCREENING^5^10
;;^UTILITY(U,$J,358.4,70,0)
;;=GENITOURINARY NEOPLASMS^6^10
;;^UTILITY(U,$J,358.4,71,0)
;;=GI CANCER^7^10
;;^UTILITY(U,$J,358.4,72,0)
;;=HEAD NECK AND LUNGS NEOPLASMS^8^10
;;^UTILITY(U,$J,358.4,73,0)
;;=HEMOGLOBINOPATHIES^9^10
;;^UTILITY(U,$J,358.4,74,0)
;;=LYMPHOID NEOPLASMS^10^10
;;^UTILITY(U,$J,358.4,75,0)
;;=METASTATIC SITES^13^10
;;^UTILITY(U,$J,358.4,76,0)
;;=MALIGNANT NEOPLASMS OF OTHER SITES^11^10
;;^UTILITY(U,$J,358.4,77,0)
;;=MYELOID NEOPLASMS AND DISORDERS^14^10
;;^UTILITY(U,$J,358.4,78,0)
;;=NEOPLASM OF UNCERTAIN BEHAVIOR^15^10
;;^UTILITY(U,$J,358.4,79,0)
;;=NEOPLASM OF UNSPECIFIED NATURE^16^10
;;^UTILITY(U,$J,358.4,80,0)
;;=PERSONAL HISTORY^19^10
;;^UTILITY(U,$J,358.4,81,0)
;;=MALNUTRITION^12^10
;;^UTILITY(U,$J,358.4,82,0)
;;=OTHER^18^10
;;^UTILITY(U,$J,358.4,83,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^20^10
;;^UTILITY(U,$J,358.4,84,0)
;;=ESTABLISHED PATIENT^1^11
;;^UTILITY(U,$J,358.4,85,0)
;;=CONSULTATIONS/OPINIONS^2^11
;;^UTILITY(U,$J,358.4,86,0)
;;=NEW PATIENTS^3^11
;;^UTILITY(U,$J,358.4,87,0)
;;=NEUROLOGY/SEIZURE^7^12
;;^UTILITY(U,$J,358.4,88,0)
;;=EEG^4^12
;;^UTILITY(U,$J,358.4,89,0)
;;=SLEEP TESTING^10^12
;;^UTILITY(U,$J,358.4,90,0)
;;=MUSCLE TESTING/EMG^6^12
;;^UTILITY(U,$J,358.4,91,0)
;;=EVOKED POTENTIAL^5^12
;;^UTILITY(U,$J,358.4,92,0)
;;=BIOPSY^2^12
;;^UTILITY(U,$J,358.4,93,0)
;;=AUTONOMIC FUNCTION TESTS^1^12
;;^UTILITY(U,$J,358.4,94,0)
;;=STEREOTACTIC^11^12
;;^UTILITY(U,$J,358.4,95,0)
;;=EDUCATION^3^12
;;^UTILITY(U,$J,358.4,96,0)
;;=NEUROSTIMULATORS^8^12
;;^UTILITY(U,$J,358.4,97,0)
;;=PROLONGED SERVICES^9^12
;;^UTILITY(U,$J,358.4,98,0)
;;=SEIZURES/EPILEPSY/SPELLS^16^13
;;^UTILITY(U,$J,358.4,99,0)
;;=CEREBROVASCULAR DISEASE^3^13
;;^UTILITY(U,$J,358.4,100,0)
;;=DIZZINESS^4^13
;;^UTILITY(U,$J,358.4,101,0)
;;=ENCEPHALOPATHY^6^13
;;^UTILITY(U,$J,358.4,102,0)
;;=HEADACHE^7^13
;;^UTILITY(U,$J,358.4,103,0)
;;=MOVEMENT DISORDERS^9^13
;;^UTILITY(U,$J,358.4,104,0)
;;=NEOPLASMS^11^13
;;^UTILITY(U,$J,358.4,105,0)
;;=NEURODEGENERATIVE DISEASE^12^13
;;^UTILITY(U,$J,358.4,106,0)
;;=OTHER^14^13
;;^UTILITY(U,$J,358.4,107,0)
;;=CARDIAC DISORDERS^2^13
;;^UTILITY(U,$J,358.4,108,0)
;;=INFLAMMATORY & DEMYELINATING DISEASES^8^13
;;^UTILITY(U,$J,358.4,109,0)
;;=NEUROMUSCULAR DISORDERS^13^13
;;^UTILITY(U,$J,358.4,110,0)
;;=PAIN^15^13
;;^UTILITY(U,$J,358.4,111,0)
;;=SPINAL CONDITIONS^18^13
;;^UTILITY(U,$J,358.4,112,0)
;;=SYMPTOMS^20^13
;;^UTILITY(U,$J,358.4,113,0)
;;=VISION DISTURBANCES^21^13
;;^UTILITY(U,$J,358.4,114,0)
;;=EMG DX^5^13
;;^UTILITY(U,$J,358.4,115,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^19^13
;;^UTILITY(U,$J,358.4,116,0)
;;=MUSCLE ATROPHY^10^13
;;^UTILITY(U,$J,358.4,117,0)
;;=BOTOX^1^13
;;^UTILITY(U,$J,358.4,118,0)
;;=SEQUELAE OF CEREBROVASCULAR DISEASE^17^13
;;^UTILITY(U,$J,358.4,119,0)
;;=ESTABLISHED PATIENT^1^14
;;^UTILITY(U,$J,358.4,120,0)
;;=CARE PLAN OVERSIGHT^1^15
;;^UTILITY(U,$J,358.4,121,0)
;;=OTHER SERVICES^4^15
;;^UTILITY(U,$J,358.4,122,0)
;;=CASE MANAGEMENT^2^15
;;^UTILITY(U,$J,358.4,123,0)
;;=EDUCATION^3^15
;;^UTILITY(U,$J,358.4,124,0)
;;=CARDIOVASCULAR DISORDERS^1^16
;;^UTILITY(U,$J,358.4,125,0)
;;=CONDITIONS AFFECTING HEALTH CARE STATUS^2^16
;;^UTILITY(U,$J,358.4,126,0)
;;=DIABETES^4^16
;;^UTILITY(U,$J,358.4,127,0)
;;=EYE & EAR DISORDERS^4^16
;;^UTILITY(U,$J,358.4,128,0)
;;=MENTAL HEALTH^5^16
;;^UTILITY(U,$J,358.4,129,0)
;;=NEOPLASMS^6^16
;;^UTILITY(U,$J,358.4,130,0)
;;=NEUROLOGICAL CONDITIONS^7^16
;;^UTILITY(U,$J,358.4,131,0)
;;=OTHER CONDITIONS^8^16
;;^UTILITY(U,$J,358.4,132,0)
;;=RESPIRATORY DISORDERS^9^16
;;^UTILITY(U,$J,358.4,133,0)
;;=DEMENTIA^3^16
;;^UTILITY(U,$J,358.4,134,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^10^16
;;^UTILITY(U,$J,358.4,135,0)
;;=ASSESSMENT/COUNSELING^1^17
;;^UTILITY(U,$J,358.4,136,0)
;;=ONE ON ONE TRAINING^6^17
;;^UTILITY(U,$J,358.4,137,0)
;;=ED/GRP/FAMILY TRNG FOR SELF MGMT^2^17
;;^UTILITY(U,$J,358.4,138,0)
;;=TEAM CONFERENCE^8^17
;;^UTILITY(U,$J,358.4,139,0)
;;=HOME VISIT^5^17
;;^UTILITY(U,$J,358.4,140,0)
;;=IMPAIRMENT CODES^1^18
;;^UTILITY(U,$J,358.4,141,0)
;;=CONTRIBUTORY CONDITION^2^18
;;^UTILITY(U,$J,358.4,142,0)
;;=TBI-RELATED CONTRIB COND^5^18
;;^UTILITY(U,$J,358.4,143,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^4^18
;;^UTILITY(U,$J,358.4,144,0)
;;=FAMILY HX EYE CONDITIONS^3^18
;;^UTILITY(U,$J,358.4,145,0)
;;=NEW PATIENT^2^19
;;^UTILITY(U,$J,358.4,146,0)
;;=ESTABLISHED PATIENT^1^19
;;^UTILITY(U,$J,358.4,147,0)
;;=CONSULTATIONS^3^19
;;^UTILITY(U,$J,358.4,148,0)
;;=ARRHYTHMIA^3^20
;;^UTILITY(U,$J,358.4,149,0)
;;=CHEST PAIN^4^20
;;^UTILITY(U,$J,358.4,150,0)
;;=CHF/MYOPATHY/TRANSPLANT^5^20
;;^UTILITY(U,$J,358.4,151,0)
;;=CORONARY ATHEROSCLEROSIS^6^20
;;^UTILITY(U,$J,358.4,152,0)
;;=GENERAL SYMPTOMS^9^20
;;^UTILITY(U,$J,358.4,153,0)
;;=HISTORY^12^20
;;^UTILITY(U,$J,358.4,154,0)
;;=HYPERTENSION/HYPOTENSION^13^20
;;^UTILITY(U,$J,358.4,155,0)
;;=INFECTION/INFLM DISEASE^14^20
;;^UTILITY(U,$J,358.4,156,0)
;;=LIPID DISORDER^15^20
;;^UTILITY(U,$J,358.4,157,0)
;;=MYOCARDIAL INFARCTION^17^20
;;^UTILITY(U,$J,358.4,158,0)
;;=NONRHEUMATIC HEART VALVE DISORDERS^18^20
;;^UTILITY(U,$J,358.4,159,0)
;;=HEART DISEASE^10^20
;;^UTILITY(U,$J,358.4,160,0)
;;=HEART VALVE DISEASE^11^20
;;^UTILITY(U,$J,358.4,161,0)
;;=PERIPHERAL VASC DISEASE^20^20
;;^UTILITY(U,$J,358.4,162,0)
;;=RHEUMATIC HEART DISEASE^23^20
;;^UTILITY(U,$J,358.4,163,0)
;;=DEVICE/IMPLANT/GRAFT^7^20
;;^UTILITY(U,$J,358.4,164,0)
;;=SYNCOPE^26^20
;;^UTILITY(U,$J,358.4,165,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^24^20
;;^UTILITY(U,$J,358.4,166,0)
;;=ECTOPY^8^20
;;^UTILITY(U,$J,358.4,167,0)
;;=MISCELLANEOUS^16^20
;;^UTILITY(U,$J,358.4,168,0)
;;=VENTRICULAR ARRHYTHMIAS^27^20
;;^UTILITY(U,$J,358.4,169,0)
;;=SUPRAVENTRICULAR ARRHYTHMIAS^25^20
;;^UTILITY(U,$J,358.4,170,0)
;;=OTHER CARDIAC CONDITIONS^22^20
;;^UTILITY(U,$J,358.4,171,0)
;;=PULMONARY DISEASE^21^20
;;^UTILITY(U,$J,358.4,172,0)
;;=PACEMAKER/AIC/DEFIBRILLATOR^19^20
;;^UTILITY(U,$J,358.4,173,0)
;;=ACSC CHF^1^20
;;^UTILITY(U,$J,358.4,174,0)
;;=ACSC HYPERTENSION^2^20
;;^UTILITY(U,$J,358.4,175,0)
;;=PACEMAKER^15^21
;;^UTILITY(U,$J,358.4,176,0)
;;=CORONARY ANGIOPLASTY & STENTS^3^21
;;^UTILITY(U,$J,358.4,177,0)
;;=ELECTROPHYSIOLOGICAL PROCs^7^21
;;^UTILITY(U,$J,358.4,178,0)
;;=PERIPHERAL ANGIOPLASTIES & STENTS^16^21
;;^UTILITY(U,$J,358.4,179,0)
;;=VASCULAR INJECTION PROCs^21^21
;;^UTILITY(U,$J,358.4,180,0)
;;=OTHER PROCEDURES^14^21
;;^UTILITY(U,$J,358.4,181,0)
;;=HEART CATHETERIZATIONS^8^21
;;^UTILITY(U,$J,358.4,182,0)
;;=CATHETERIZATIONS FOR INT RADIOLOGY^2^21
;;^UTILITY(U,$J,358.4,183,0)
;;=OTHER HEART CODES^13^21
;;^UTILITY(U,$J,358.4,184,0)
;;=PROSTHETIC ANEURYSM REPAIR^19^21
;;^UTILITY(U,$J,358.4,185,0)
;;=DEVICE PROGRAMMING^4^21
;;^UTILITY(U,$J,358.4,186,0)
;;=ECHO^5^21
;;^UTILITY(U,$J,358.4,187,0)
;;=EKG^6^21
;;^UTILITY(U,$J,358.4,188,0)
;;=MEDICATION ADMINISTRATION^9^21
;;^UTILITY(U,$J,358.4,189,0)
;;=MEDICATIONS^10^21
;;^UTILITY(U,$J,358.4,190,0)
;;=OTHER CARDIAC^12^21
;;^UTILITY(U,$J,358.4,191,0)
;;=STRESS TESTS^20^21
;;^UTILITY(U,$J,358.4,192,0)
;;=PREVENTIVE COUNSELING^17^21
;;^UTILITY(U,$J,358.4,193,0)
;;=MODERATE SEDATION (MS)^11^21
;;^UTILITY(U,$J,358.4,194,0)
;;=VENTRICULAR ASSIST DEVICE INSERTION^22^21
;;^UTILITY(U,$J,358.4,195,0)
;;=CARDIOVERSION^1^21
;;^UTILITY(U,$J,358.4,196,0)
;;=PROLONGED SERVICES^18^21
;;^UTILITY(U,$J,358.4,197,0)
;;=NEW PATIENT^2^22
;;^UTILITY(U,$J,358.4,198,0)
;;=ESTABLISHED PATIENT^1^22
;;^UTILITY(U,$J,358.4,199,0)
;;=CONSULTATIONS^3^22
;;^UTILITY(U,$J,358.4,200,0)
;;=MISCELLANEOUS TREATMENT^4^23
;;^UTILITY(U,$J,358.4,201,0)
;;=CHIROPRACTIC MANIPULATIVE SERVICES^2^23
;;^UTILITY(U,$J,358.4,202,0)
;;=OSTEOPATHIC MANIPULATIVE TREATMENT^5^23
;;^UTILITY(U,$J,358.4,203,0)
;;=ACUPUNCTURE^1^23
;;^UTILITY(U,$J,358.4,204,0)
;;=EDUCATION FOR SELF MGT^3^23
;;^UTILITY(U,$J,358.4,205,0)
;;=EXTREMITIES/JOINTS/MUSCLES^6^24
;;^UTILITY(U,$J,358.4,206,0)
;;=HEAD AREA/NERVES^1^24
;;^UTILITY(U,$J,358.4,207,0)
;;=CERVICAL^2^24
;;^UTILITY(U,$J,358.4,208,0)
;;=THORACIC^3^24
;;^UTILITY(U,$J,358.4,209,0)
;;=LUMBAR^4^24
;;^UTILITY(U,$J,358.4,210,0)
;;=SACRUM^5^24
;;^UTILITY(U,$J,358.4,211,0)
;;=UNSPECIFIED^8^24
;;^UTILITY(U,$J,358.4,212,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^7^24
;;^UTILITY(U,$J,358.4,213,0)
;;=NEW PATIENT^1^25
;;^UTILITY(U,$J,358.4,214,0)
;;=ESTABLISHED PATIENT^2^25
;;^UTILITY(U,$J,358.4,215,0)
;;=EDUCATION & TRAINING FOR SELF MGMT^4^25
;;^UTILITY(U,$J,358.4,216,0)
;;=MEDICATION ADMIN^7^25
;;^UTILITY(U,$J,358.4,217,0)
;;=IMMUNIZATION ADMINISTRATION^5^25
;;^UTILITY(U,$J,358.4,218,0)
;;=IMMUNIZATIONS^6^25
;;^UTILITY(U,$J,358.4,219,0)
;;=CONTINUOUS GLUCOSE MONITORING^3^25
;;^UTILITY(U,$J,358.4,220,0)
;;=ANTICOAGULATION^2^26
;;^UTILITY(U,$J,358.4,221,0)
;;=PAIN^6^26
;;^UTILITY(U,$J,358.4,222,0)
;;=MENTAL HEALTH^5^26
;;^UTILITY(U,$J,358.4,223,0)
;;=ENDOCRINE^4^26
;;^UTILITY(U,$J,358.4,224,0)
;;=CARDIOVASCULAR^3^26
;;^UTILITY(U,$J,358.4,225,0)
;;=RESPIRATORY^7^26
;;^UTILITY(U,$J,358.4,226,0)
;;=OTHER^8^26
;;^UTILITY(U,$J,358.4,227,0)
;;=COMMON DIAGNOSIS^1^26
;;^UTILITY(U,$J,358.4,228,0)
;;=NEW PATIENT^3^27
;;^UTILITY(U,$J,358.4,229,0)
;;=ESTABLISHED PATIENT^1^27
;;^UTILITY(U,$J,358.4,230,0)
;;=CONSULTATIONS^2^27
;;^UTILITY(U,$J,358.4,231,0)
;;=PREVENTIVE MEDICINE-EST PT^4^27
;;^UTILITY(U,$J,358.4,232,0)
;;=PREVENTIVE MEDICINE-NEW PT^5^27
;;^UTILITY(U,$J,358.4,233,0)
;;=RISK FACTOR REDUCTION-GRP^6^27
;;^UTILITY(U,$J,358.4,234,0)
;;=RISK FACTOR REDUCTION-IND^7^27
;;^UTILITY(U,$J,358.4,235,0)
;;=OTHER^3^28
;;^UTILITY(U,$J,358.4,236,0)
;;=EDUCATION/TRAINING^1^28
;;^UTILITY(U,$J,358.4,237,0)
;;=MEDICAL NUTRITION THERAPY^2^28
;;^UTILITY(U,$J,358.4,238,0)
;;=WOUND TREATMENT^5^28
;;^UTILITY(U,$J,358.4,239,0)
;;=PROLONGED SERVICES^4^28
;;^UTILITY(U,$J,358.4,240,0)
;;=DIABETES^1^29
;;^UTILITY(U,$J,358.4,241,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^3^29
;;^UTILITY(U,$J,358.4,242,0)
;;=SOCIAL DETERMINANTS OF HEALTH^2^29
;;^UTILITY(U,$J,358.4,243,0)
;;=IMMUNIZATION^10^30
;;^UTILITY(U,$J,358.4,244,0)
;;=MEDICATION^13^30
;;^UTILITY(U,$J,358.4,245,0)
;;=ORTHO/JOINTS^6^30
;;^UTILITY(U,$J,358.4,246,0)
;;=RESPIRATORY SYSTEM^14^30
;;^UTILITY(U,$J,358.4,247,0)
;;=CRITICAL CARE/PULM/SEDATION^3^30
;;^UTILITY(U,$J,358.4,248,0)
;;=GI/GYN^7^30
;;^UTILITY(U,$J,358.4,249,0)
;;=NEURO/EYE/ENT^8^30
;;^UTILITY(U,$J,358.4,250,0)
;;=LACERATIONS^5^30
;;^UTILITY(U,$J,358.4,251,0)
;;=SKIN WOUNDS/BURNS^4^30
;;^UTILITY(U,$J,358.4,252,0)
;;=PSYCHIATRY^9^30
;;^UTILITY(U,$J,358.4,253,0)
;;=COMMON PROCEDURES^1^30
;;^UTILITY(U,$J,358.4,254,0)
;;=INFUSION/INJECTION ADMIN^11^30
;;^UTILITY(U,$J,358.4,255,0)
;;=ADDITIONAL VISIT CODES^2^30
;;^UTILITY(U,$J,358.4,256,0)
;;=COVID-19 RELATED^12^30
;;^UTILITY(U,$J,358.4,257,0)
;;=HEDIS CODE/MISC HCPCS^15^30
;;^UTILITY(U,$J,358.4,258,0)
;;=LABS PERFORMED IN ED^16^30
;;^UTILITY(U,$J,358.4,259,0)
;;=EMERGENCY DEPT VISIT^1^31
;;^UTILITY(U,$J,358.4,260,0)
;;=TRIAGE ONLY (NO MD SEEN)^4^31
;;^UTILITY(U,$J,358.4,261,0)
;;=ED OBS 1ST DAY-INIT^3^31
;;^UTILITY(U,$J,358.4,262,0)
;;=ED OBS (ADMIT&D/C SAME DAY)^2^31
;;^UTILITY(U,$J,358.4,263,0)
;;=ED COMMON DIAGNOSES^1^32
;;^UTILITY(U,$J,358.4,264,0)
;;=ADMINISTRATIVE TOPICS^2^32
;;^UTILITY(U,$J,358.4,265,0)
;;=CARDIOVASCULAR^3^32
;;^UTILITY(U,$J,358.4,266,0)
;;=EAR/NOSE/THROAT^6^32
;;^UTILITY(U,$J,358.4,267,0)
;;=ENDO/RENAL/ELECTROLYTES^5^32
;;^UTILITY(U,$J,358.4,268,0)
;;=EYE^7^32
;;^UTILITY(U,$J,358.4,269,0)
;;=GI/ABDOMEN^8^32
;;^UTILITY(U,$J,358.4,270,0)
;;=PSYCHIATRY^17^32
;;^UTILITY(U,$J,358.4,271,0)
;;=LACERATION(S)^16^32
;;^UTILITY(U,$J,358.4,272,0)
;;=PULMONARY^18^32
;;^UTILITY(U,$J,358.4,273,0)
;;=GU/RECTAL^9^32
;;^UTILITY(U,$J,358.4,274,0)
;;=HEME/ONC/VASCULAR^10^32
;;^UTILITY(U,$J,358.4,275,0)
;;=INFECTIOUS DISEASE^11^32
;;^UTILITY(U,$J,358.4,276,0)
;;=MUSCULOSKELETAL/MISC^14^32
;;^UTILITY(U,$J,358.4,277,0)
;;=NEUROLOGY^15^32
;;^UTILITY(U,$J,358.4,278,0)
;;=SKIN^19^32
;;^UTILITY(U,$J,358.4,279,0)
;;=MUSCULOSKELETAL-LE^12^32
;;^UTILITY(U,$J,358.4,280,0)
;;=MUSCULOSKELETAL-UE^13^32
;;^UTILITY(U,$J,358.4,281,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^21^32
;;^UTILITY(U,$J,358.4,282,0)
;;=E-CIG/VAPE LUNG INJURY (EVAL)^4^32
;;^UTILITY(U,$J,358.4,283,0)
;;=FALLS^22^32
;;^UTILITY(U,$J,358.4,284,0)
;;=VEHICLE ACCIDENTS^24^32
;;^UTILITY(U,$J,358.4,285,0)
;;=EXTERNAL CAUSES^26^32
;;^UTILITY(U,$J,358.4,286,0)
;;=PAIN^20^32
;;^UTILITY(U,$J,358.4,287,0)
;;=BITES-HUMAN/ANIMAL/INSECT^23^32
;;^UTILITY(U,$J,358.4,288,0)
;;=SUSPECTED COND R/O AFTER OBS^25^32
;;^UTILITY(U,$J,358.4,289,0)
;;=NEW PATIENT^2^33
;;^UTILITY(U,$J,358.4,290,0)
;;=ESTABLISHED PATIENT^1^33
;;^UTILITY(U,$J,358.4,291,0)
;;=CONSULTATIONS^3^33
;;^UTILITY(U,$J,358.4,292,0)
;;=ENDOCRINE DX^1^34
;;^UTILITY(U,$J,358.4,293,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^3^34
;;^UTILITY(U,$J,358.4,294,0)
;;=SOCIAL DETERMINANTS OF HEALTH^2^34
;;^UTILITY(U,$J,358.4,295,0)
;;=BIOPSIES^1^35
;;^UTILITY(U,$J,358.4,296,0)
;;=INJECTIONS & INFUSIONS^2^35
;;^UTILITY(U,$J,358.4,297,0)
;;=OTHER^4^35
;;^UTILITY(U,$J,358.4,298,0)
;;=PROLONGED CLINICAL STAFF SERVICES^5^35
;;^UTILITY(U,$J,358.4,299,0)
;;=LAB TESTS^3^35
;;^UTILITY(U,$J,358.4,300,0)
;;=TEST - CATARACT / COLOR^4^36
;;^UTILITY(U,$J,358.4,301,0)
;;=IMAGING / PHOTOS^2^36
;;^UTILITY(U,$J,358.4,302,0)
;;=TEST - GLAUCOMA^3^36
;;^UTILITY(U,$J,358.4,303,0)
;;=TEST - OTHER^5^36
;;^UTILITY(U,$J,358.4,304,0)
;;=REFRACT / GLASSES / CL^1^36
;;^UTILITY(U,$J,358.4,305,0)
;;=EEF Version 2022 July^6^36
;;^UTILITY(U,$J,358.4,306,0)
;;=LOW VISION / BLINDNESS^21^37
;;^UTILITY(U,$J,358.4,307,0)
;;=RETINA - VASCULAR^12^37
;;^UTILITY(U,$J,358.4,308,0)
;;=EYELIDS / LASHES^2^37
;;^UTILITY(U,$J,358.4,309,0)
;;=NEURO / STRABISMUS^18^37
;;^UTILITY(U,$J,358.4,310,0)
;;=ORBIT - PLASTICS^20^37
;;^UTILITY(U,$J,358.4,311,0)
;;=VITREOUS^17^37
;;^UTILITY(U,$J,358.4,312,0)
;;=ORBIT - TRAUMA^19^37
;;^UTILITY(U,$J,358.4,313,0)
;;=LACRIMAL / NLD / NEOPLASMS^3^37
;;^UTILITY(U,$J,358.4,314,0)
;;=MOST FREQUENT^1^37
;;^UTILITY(U,$J,358.4,315,0)
;;=CONJUNCTIVA / SCLERA^4^37
;;^UTILITY(U,$J,358.4,316,0)
;;=CORNEA / ULCER^5^37
;;^UTILITY(U,$J,358.4,317,0)
;;=LENS / CATARACT / POSTOP^6^37
;;^UTILITY(U,$J,358.4,318,0)
;;=IRIS / UVEITIS^7^37
;;^UTILITY(U,$J,358.4,319,0)
;;=GLAUCOMA - OPEN ANGLE^8^37
;;^UTILITY(U,$J,358.4,320,0)
;;=GLAUCOMA - CLOSED ANGLE^9^37
;;^UTILITY(U,$J,358.4,321,0)
;;=GLAUCOMA - SECONDARY^10^37
;;^UTILITY(U,$J,358.4,322,0)
;;=RETINA - CHOROID / TUMORS / INFLAM^14^37
;;^UTILITY(U,$J,358.4,323,0)
;;=RETINA - TEAR / PERIPH / DEGENERATION^15^37
;;^UTILITY(U,$J,358.4,324,0)
;;=RETINA - MACULA^11^37
;;^UTILITY(U,$J,358.4,325,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^23^37
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0BE 19790 printed Sep 23, 2025@19:21:20 Page 2
IBDEI0BE ; ; 01-AUG-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
+2 if 'DIFQR(358.4)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.4)
+2 ;;=^IBE(358.4,
+3 ;;^UTILITY(U,$J,358.4,0)
+4 ;;=IMP/EXP SELECTION GROUP^358.4I^1182^1174
+5 ;;^UTILITY(U,$J,358.4,1,0)
+6 ;;=PHYSICIAN TELEPHONE CODES^1^1
+7 ;;^UTILITY(U,$J,358.4,2,0)
+8 ;;=NON-PHYSICIAN TELEPHONE CALLS^2^1
+9 ;;^UTILITY(U,$J,358.4,3,0)
+10 ;;=SEIZURES/EPILEPSY/SPELLS^1^2
+11 ;;^UTILITY(U,$J,358.4,4,0)
+12 ;;=CEREBROVASCULAR DISEASE^2^2
+13 ;;^UTILITY(U,$J,358.4,5,0)
+14 ;;=DIZZINESS^3^2
+15 ;;^UTILITY(U,$J,358.4,6,0)
+16 ;;=ENCEPHALOPATHY^4^2
+17 ;;^UTILITY(U,$J,358.4,7,0)
+18 ;;=HEADACHE^5^2
+19 ;;^UTILITY(U,$J,358.4,8,0)
+20 ;;=MOVEMENT DISORDERS^6^2
+21 ;;^UTILITY(U,$J,358.4,9,0)
+22 ;;=NEOPLASMS^7^2
+23 ;;^UTILITY(U,$J,358.4,10,0)
+24 ;;=NEURODEGENERATIVE DISEASE^8^2
+25 ;;^UTILITY(U,$J,358.4,11,0)
+26 ;;=SLEEP DISORDERS^9^2
+27 ;;^UTILITY(U,$J,358.4,12,0)
+28 ;;=SPECIAL SCREENING^10^2
+29 ;;^UTILITY(U,$J,358.4,13,0)
+30 ;;=OTHER^11^2
+31 ;;^UTILITY(U,$J,358.4,14,0)
+32 ;;=BODY MASS INDEX (BMI)^2^3
+33 ;;^UTILITY(U,$J,358.4,15,0)
+34 ;;=COUNSELING^3^3
+35 ;;^UTILITY(U,$J,358.4,16,0)
+36 ;;=PREVENTIVE HEALTH ENCOUNTER^1^3
+37 ;;^UTILITY(U,$J,358.4,17,0)
+38 ;;=HISTORY OF ILLNESS^4^3
+39 ;;^UTILITY(U,$J,358.4,18,0)
+40 ;;=LONG TERM DRUG USE^5^3
+41 ;;^UTILITY(U,$J,358.4,19,0)
+42 ;;=OTHER^11^3
+43 ;;^UTILITY(U,$J,358.4,20,0)
+44 ;;=SCREENING^6^3
+45 ;;^UTILITY(U,$J,358.4,21,0)
+46 ;;=TRANSPLANT^8^3
+47 ;;^UTILITY(U,$J,358.4,22,0)
+48 ;;=VACCINATIONS^9^3
+49 ;;^UTILITY(U,$J,358.4,23,0)
+50 ;;=WOMEN'S HEALTH^10^3
+51 ;;^UTILITY(U,$J,358.4,24,0)
+52 ;;=SUICIDE IDEATIONS/ATTEMPTS^7^3
+53 ;;^UTILITY(U,$J,358.4,25,0)
+54 ;;=IMMUNIZATIONS^4^4
+55 ;;^UTILITY(U,$J,358.4,26,0)
+56 ;;=BEHAVIOR CHANGE INTERVENTION,INDIVIDUAL^1^4
+57 ;;^UTILITY(U,$J,358.4,27,0)
+58 ;;=COUNSELING RISK FACTOR REDUCTION^2^4
+59 ;;^UTILITY(U,$J,358.4,28,0)
+60 ;;=OTH PREVENTIVE MEDICINE SERVICES^5^4
+61 ;;^UTILITY(U,$J,358.4,29,0)
+62 ;;=PREVENTIVE MEDICINE,GROUP^8^4
+63 ;;^UTILITY(U,$J,358.4,30,0)
+64 ;;=PREVENTIVE HEALTH VISIT-EST PT^6^4
+65 ;;^UTILITY(U,$J,358.4,31,0)
+66 ;;=PREVENTIVE HEALTH VISIT-NEW PT^7^4
+67 ;;^UTILITY(U,$J,358.4,32,0)
+68 ;;=IMMUNIZATION ADMINISTRATION^3^4
+69 ;;^UTILITY(U,$J,358.4,33,0)
+70 ;;=RESPIRATORY^6^5
+71 ;;^UTILITY(U,$J,358.4,34,0)
+72 ;;=SLEEP TESTING AND EVAL^7^5
+73 ;;^UTILITY(U,$J,358.4,35,0)
+74 ;;=OXIMETRY^4^5
+75 ;;^UTILITY(U,$J,358.4,36,0)
+76 ;;=CPAP^1^5
+77 ;;^UTILITY(U,$J,358.4,37,0)
+78 ;;=EDUCATION/TRAINING^2^5
+79 ;;^UTILITY(U,$J,358.4,38,0)
+80 ;;=PROLONGED CLINICAL STAFF SERVICES^5^5
+81 ;;^UTILITY(U,$J,358.4,39,0)
+82 ;;=HOME SLEEP STUDIES^3^5
+83 ;;^UTILITY(U,$J,358.4,40,0)
+84 ;;=TELEHEALTH PATIENT SITE^8^5
+85 ;;^UTILITY(U,$J,358.4,41,0)
+86 ;;=WIRELESS MONITOR OF PAP DEVICES^9^5
+87 ;;^UTILITY(U,$J,358.4,42,0)
+88 ;;=NEW PATIENT^2^6
+89 ;;^UTILITY(U,$J,358.4,43,0)
+90 ;;=ESTABLISHED PATIENT^1^6
+91 ;;^UTILITY(U,$J,358.4,44,0)
+92 ;;=CONSULTATIONS^3^6
+93 ;;^UTILITY(U,$J,358.4,45,0)
+94 ;;=PULMONARY DIAGNOSES^2^7
+95 ;;^UTILITY(U,$J,358.4,46,0)
+96 ;;=SLEEP DX PRELIMINARY^3^7
+97 ;;^UTILITY(U,$J,358.4,47,0)
+98 ;;=SLEEP DX CONFIRMED^4^7
+99 ;;^UTILITY(U,$J,358.4,48,0)
+100 ;;=OTHER SLEEP RELATED DX^6^7
+101 ;;^UTILITY(U,$J,358.4,49,0)
+102 ;;=SUICIDE IDEATIONS/ATTEMPTS^5^7
+103 ;;^UTILITY(U,$J,358.4,50,0)
+104 ;;=OBESITY & BMI DX^1^7
+105 ;;^UTILITY(U,$J,358.4,51,0)
+106 ;;=SPECIAL SERVICES^10^8
+107 ;;^UTILITY(U,$J,358.4,52,0)
+108 ;;=CHEMO NURSE PROCEDURES^2^8
+109 ;;^UTILITY(U,$J,358.4,53,0)
+110 ;;=INFUSION DRUGS^7^8
+111 ;;^UTILITY(U,$J,358.4,54,0)
+112 ;;=BLOOD PRODUCTS^1^8
+113 ;;^UTILITY(U,$J,358.4,55,0)
+114 ;;=DIAGNOSTIC PROCEDURES^3^8
+115 ;;^UTILITY(U,$J,358.4,56,0)
+116 ;;=OTHER DRUGS^8^8
+117 ;;^UTILITY(U,$J,358.4,57,0)
+118 ;;=IMMUNIZATION ADMINISTRATION^5^8
+119 ;;^UTILITY(U,$J,358.4,58,0)
+120 ;;=IMMUNIZATIONS^6^8
+121 ;;^UTILITY(U,$J,358.4,59,0)
+122 ;;=PROLONGED SVC-MD/NP/PA^9^8
+123 ;;^UTILITY(U,$J,358.4,60,0)
+124 ;;=EDUCATION/TRAINING^4^8
+125 ;;^UTILITY(U,$J,358.4,61,0)
+126 ;;=NEW PATIENT^2^9
+127 ;;^UTILITY(U,$J,358.4,62,0)
+128 ;;=ESTABLISHED PATIENT^1^9
+129 ;;^UTILITY(U,$J,358.4,63,0)
+130 ;;=CONSULTATIONS^3^9
+131 ;;^UTILITY(U,$J,358.4,64,0)
+132 ;;=COMPLEX CHRONIC CARE^4^9
+133 ;;^UTILITY(U,$J,358.4,65,0)
+134 ;;=ANEMIA^1^10
+135 ;;^UTILITY(U,$J,358.4,66,0)
+136 ;;=ARTIFICIAL OPENING STATUS^2^10
+137 ;;^UTILITY(U,$J,358.4,67,0)
+138 ;;=BREASTS and GYN NEOPLASMS^3^10
+139 ;;^UTILITY(U,$J,358.4,68,0)
+140 ;;=COAGULATION DISORDERS^4^10
+141 ;;^UTILITY(U,$J,358.4,69,0)
+142 ;;=COUNSELING AND SCREENING^5^10
+143 ;;^UTILITY(U,$J,358.4,70,0)
+144 ;;=GENITOURINARY NEOPLASMS^6^10
+145 ;;^UTILITY(U,$J,358.4,71,0)
+146 ;;=GI CANCER^7^10
+147 ;;^UTILITY(U,$J,358.4,72,0)
+148 ;;=HEAD NECK AND LUNGS NEOPLASMS^8^10
+149 ;;^UTILITY(U,$J,358.4,73,0)
+150 ;;=HEMOGLOBINOPATHIES^9^10
+151 ;;^UTILITY(U,$J,358.4,74,0)
+152 ;;=LYMPHOID NEOPLASMS^10^10
+153 ;;^UTILITY(U,$J,358.4,75,0)
+154 ;;=METASTATIC SITES^13^10
+155 ;;^UTILITY(U,$J,358.4,76,0)
+156 ;;=MALIGNANT NEOPLASMS OF OTHER SITES^11^10
+157 ;;^UTILITY(U,$J,358.4,77,0)
+158 ;;=MYELOID NEOPLASMS AND DISORDERS^14^10
+159 ;;^UTILITY(U,$J,358.4,78,0)
+160 ;;=NEOPLASM OF UNCERTAIN BEHAVIOR^15^10
+161 ;;^UTILITY(U,$J,358.4,79,0)
+162 ;;=NEOPLASM OF UNSPECIFIED NATURE^16^10
+163 ;;^UTILITY(U,$J,358.4,80,0)
+164 ;;=PERSONAL HISTORY^19^10
+165 ;;^UTILITY(U,$J,358.4,81,0)
+166 ;;=MALNUTRITION^12^10
+167 ;;^UTILITY(U,$J,358.4,82,0)
+168 ;;=OTHER^18^10
+169 ;;^UTILITY(U,$J,358.4,83,0)
+170 ;;=SUICIDE IDEATIONS/ATTEMPTS^20^10
+171 ;;^UTILITY(U,$J,358.4,84,0)
+172 ;;=ESTABLISHED PATIENT^1^11
+173 ;;^UTILITY(U,$J,358.4,85,0)
+174 ;;=CONSULTATIONS/OPINIONS^2^11
+175 ;;^UTILITY(U,$J,358.4,86,0)
+176 ;;=NEW PATIENTS^3^11
+177 ;;^UTILITY(U,$J,358.4,87,0)
+178 ;;=NEUROLOGY/SEIZURE^7^12
+179 ;;^UTILITY(U,$J,358.4,88,0)
+180 ;;=EEG^4^12
+181 ;;^UTILITY(U,$J,358.4,89,0)
+182 ;;=SLEEP TESTING^10^12
+183 ;;^UTILITY(U,$J,358.4,90,0)
+184 ;;=MUSCLE TESTING/EMG^6^12
+185 ;;^UTILITY(U,$J,358.4,91,0)
+186 ;;=EVOKED POTENTIAL^5^12
+187 ;;^UTILITY(U,$J,358.4,92,0)
+188 ;;=BIOPSY^2^12
+189 ;;^UTILITY(U,$J,358.4,93,0)
+190 ;;=AUTONOMIC FUNCTION TESTS^1^12
+191 ;;^UTILITY(U,$J,358.4,94,0)
+192 ;;=STEREOTACTIC^11^12
+193 ;;^UTILITY(U,$J,358.4,95,0)
+194 ;;=EDUCATION^3^12
+195 ;;^UTILITY(U,$J,358.4,96,0)
+196 ;;=NEUROSTIMULATORS^8^12
+197 ;;^UTILITY(U,$J,358.4,97,0)
+198 ;;=PROLONGED SERVICES^9^12
+199 ;;^UTILITY(U,$J,358.4,98,0)
+200 ;;=SEIZURES/EPILEPSY/SPELLS^16^13
+201 ;;^UTILITY(U,$J,358.4,99,0)
+202 ;;=CEREBROVASCULAR DISEASE^3^13
+203 ;;^UTILITY(U,$J,358.4,100,0)
+204 ;;=DIZZINESS^4^13
+205 ;;^UTILITY(U,$J,358.4,101,0)
+206 ;;=ENCEPHALOPATHY^6^13
+207 ;;^UTILITY(U,$J,358.4,102,0)
+208 ;;=HEADACHE^7^13
+209 ;;^UTILITY(U,$J,358.4,103,0)
+210 ;;=MOVEMENT DISORDERS^9^13
+211 ;;^UTILITY(U,$J,358.4,104,0)
+212 ;;=NEOPLASMS^11^13
+213 ;;^UTILITY(U,$J,358.4,105,0)
+214 ;;=NEURODEGENERATIVE DISEASE^12^13
+215 ;;^UTILITY(U,$J,358.4,106,0)
+216 ;;=OTHER^14^13
+217 ;;^UTILITY(U,$J,358.4,107,0)
+218 ;;=CARDIAC DISORDERS^2^13
+219 ;;^UTILITY(U,$J,358.4,108,0)
+220 ;;=INFLAMMATORY & DEMYELINATING DISEASES^8^13
+221 ;;^UTILITY(U,$J,358.4,109,0)
+222 ;;=NEUROMUSCULAR DISORDERS^13^13
+223 ;;^UTILITY(U,$J,358.4,110,0)
+224 ;;=PAIN^15^13
+225 ;;^UTILITY(U,$J,358.4,111,0)
+226 ;;=SPINAL CONDITIONS^18^13
+227 ;;^UTILITY(U,$J,358.4,112,0)
+228 ;;=SYMPTOMS^20^13
+229 ;;^UTILITY(U,$J,358.4,113,0)
+230 ;;=VISION DISTURBANCES^21^13
+231 ;;^UTILITY(U,$J,358.4,114,0)
+232 ;;=EMG DX^5^13
+233 ;;^UTILITY(U,$J,358.4,115,0)
+234 ;;=SUICIDE IDEATIONS/ATTEMPTS^19^13
+235 ;;^UTILITY(U,$J,358.4,116,0)
+236 ;;=MUSCLE ATROPHY^10^13
+237 ;;^UTILITY(U,$J,358.4,117,0)
+238 ;;=BOTOX^1^13
+239 ;;^UTILITY(U,$J,358.4,118,0)
+240 ;;=SEQUELAE OF CEREBROVASCULAR DISEASE^17^13
+241 ;;^UTILITY(U,$J,358.4,119,0)
+242 ;;=ESTABLISHED PATIENT^1^14
+243 ;;^UTILITY(U,$J,358.4,120,0)
+244 ;;=CARE PLAN OVERSIGHT^1^15
+245 ;;^UTILITY(U,$J,358.4,121,0)
+246 ;;=OTHER SERVICES^4^15
+247 ;;^UTILITY(U,$J,358.4,122,0)
+248 ;;=CASE MANAGEMENT^2^15
+249 ;;^UTILITY(U,$J,358.4,123,0)
+250 ;;=EDUCATION^3^15
+251 ;;^UTILITY(U,$J,358.4,124,0)
+252 ;;=CARDIOVASCULAR DISORDERS^1^16
+253 ;;^UTILITY(U,$J,358.4,125,0)
+254 ;;=CONDITIONS AFFECTING HEALTH CARE STATUS^2^16
+255 ;;^UTILITY(U,$J,358.4,126,0)
+256 ;;=DIABETES^4^16
+257 ;;^UTILITY(U,$J,358.4,127,0)
+258 ;;=EYE & EAR DISORDERS^4^16
+259 ;;^UTILITY(U,$J,358.4,128,0)
+260 ;;=MENTAL HEALTH^5^16
+261 ;;^UTILITY(U,$J,358.4,129,0)
+262 ;;=NEOPLASMS^6^16
+263 ;;^UTILITY(U,$J,358.4,130,0)
+264 ;;=NEUROLOGICAL CONDITIONS^7^16
+265 ;;^UTILITY(U,$J,358.4,131,0)
+266 ;;=OTHER CONDITIONS^8^16
+267 ;;^UTILITY(U,$J,358.4,132,0)
+268 ;;=RESPIRATORY DISORDERS^9^16
+269 ;;^UTILITY(U,$J,358.4,133,0)
+270 ;;=DEMENTIA^3^16
+271 ;;^UTILITY(U,$J,358.4,134,0)
+272 ;;=SUICIDE IDEATIONS/ATTEMPTS^10^16
+273 ;;^UTILITY(U,$J,358.4,135,0)
+274 ;;=ASSESSMENT/COUNSELING^1^17
+275 ;;^UTILITY(U,$J,358.4,136,0)
+276 ;;=ONE ON ONE TRAINING^6^17
+277 ;;^UTILITY(U,$J,358.4,137,0)
+278 ;;=ED/GRP/FAMILY TRNG FOR SELF MGMT^2^17
+279 ;;^UTILITY(U,$J,358.4,138,0)
+280 ;;=TEAM CONFERENCE^8^17
+281 ;;^UTILITY(U,$J,358.4,139,0)
+282 ;;=HOME VISIT^5^17
+283 ;;^UTILITY(U,$J,358.4,140,0)
+284 ;;=IMPAIRMENT CODES^1^18
+285 ;;^UTILITY(U,$J,358.4,141,0)
+286 ;;=CONTRIBUTORY CONDITION^2^18
+287 ;;^UTILITY(U,$J,358.4,142,0)
+288 ;;=TBI-RELATED CONTRIB COND^5^18
+289 ;;^UTILITY(U,$J,358.4,143,0)
+290 ;;=SUICIDE IDEATIONS/ATTEMPTS^4^18
+291 ;;^UTILITY(U,$J,358.4,144,0)
+292 ;;=FAMILY HX EYE CONDITIONS^3^18
+293 ;;^UTILITY(U,$J,358.4,145,0)
+294 ;;=NEW PATIENT^2^19
+295 ;;^UTILITY(U,$J,358.4,146,0)
+296 ;;=ESTABLISHED PATIENT^1^19
+297 ;;^UTILITY(U,$J,358.4,147,0)
+298 ;;=CONSULTATIONS^3^19
+299 ;;^UTILITY(U,$J,358.4,148,0)
+300 ;;=ARRHYTHMIA^3^20
+301 ;;^UTILITY(U,$J,358.4,149,0)
+302 ;;=CHEST PAIN^4^20
+303 ;;^UTILITY(U,$J,358.4,150,0)
+304 ;;=CHF/MYOPATHY/TRANSPLANT^5^20
+305 ;;^UTILITY(U,$J,358.4,151,0)
+306 ;;=CORONARY ATHEROSCLEROSIS^6^20
+307 ;;^UTILITY(U,$J,358.4,152,0)
+308 ;;=GENERAL SYMPTOMS^9^20
+309 ;;^UTILITY(U,$J,358.4,153,0)
+310 ;;=HISTORY^12^20
+311 ;;^UTILITY(U,$J,358.4,154,0)
+312 ;;=HYPERTENSION/HYPOTENSION^13^20
+313 ;;^UTILITY(U,$J,358.4,155,0)
+314 ;;=INFECTION/INFLM DISEASE^14^20
+315 ;;^UTILITY(U,$J,358.4,156,0)
+316 ;;=LIPID DISORDER^15^20
+317 ;;^UTILITY(U,$J,358.4,157,0)
+318 ;;=MYOCARDIAL INFARCTION^17^20
+319 ;;^UTILITY(U,$J,358.4,158,0)
+320 ;;=NONRHEUMATIC HEART VALVE DISORDERS^18^20
+321 ;;^UTILITY(U,$J,358.4,159,0)
+322 ;;=HEART DISEASE^10^20
+323 ;;^UTILITY(U,$J,358.4,160,0)
+324 ;;=HEART VALVE DISEASE^11^20
+325 ;;^UTILITY(U,$J,358.4,161,0)
+326 ;;=PERIPHERAL VASC DISEASE^20^20
+327 ;;^UTILITY(U,$J,358.4,162,0)
+328 ;;=RHEUMATIC HEART DISEASE^23^20
+329 ;;^UTILITY(U,$J,358.4,163,0)
+330 ;;=DEVICE/IMPLANT/GRAFT^7^20
+331 ;;^UTILITY(U,$J,358.4,164,0)
+332 ;;=SYNCOPE^26^20
+333 ;;^UTILITY(U,$J,358.4,165,0)
+334 ;;=SUICIDE IDEATIONS/ATTEMPTS^24^20
+335 ;;^UTILITY(U,$J,358.4,166,0)
+336 ;;=ECTOPY^8^20
+337 ;;^UTILITY(U,$J,358.4,167,0)
+338 ;;=MISCELLANEOUS^16^20
+339 ;;^UTILITY(U,$J,358.4,168,0)
+340 ;;=VENTRICULAR ARRHYTHMIAS^27^20
+341 ;;^UTILITY(U,$J,358.4,169,0)
+342 ;;=SUPRAVENTRICULAR ARRHYTHMIAS^25^20
+343 ;;^UTILITY(U,$J,358.4,170,0)
+344 ;;=OTHER CARDIAC CONDITIONS^22^20
+345 ;;^UTILITY(U,$J,358.4,171,0)
+346 ;;=PULMONARY DISEASE^21^20
+347 ;;^UTILITY(U,$J,358.4,172,0)
+348 ;;=PACEMAKER/AIC/DEFIBRILLATOR^19^20
+349 ;;^UTILITY(U,$J,358.4,173,0)
+350 ;;=ACSC CHF^1^20
+351 ;;^UTILITY(U,$J,358.4,174,0)
+352 ;;=ACSC HYPERTENSION^2^20
+353 ;;^UTILITY(U,$J,358.4,175,0)
+354 ;;=PACEMAKER^15^21
+355 ;;^UTILITY(U,$J,358.4,176,0)
+356 ;;=CORONARY ANGIOPLASTY & STENTS^3^21
+357 ;;^UTILITY(U,$J,358.4,177,0)
+358 ;;=ELECTROPHYSIOLOGICAL PROCs^7^21
+359 ;;^UTILITY(U,$J,358.4,178,0)
+360 ;;=PERIPHERAL ANGIOPLASTIES & STENTS^16^21
+361 ;;^UTILITY(U,$J,358.4,179,0)
+362 ;;=VASCULAR INJECTION PROCs^21^21
+363 ;;^UTILITY(U,$J,358.4,180,0)
+364 ;;=OTHER PROCEDURES^14^21
+365 ;;^UTILITY(U,$J,358.4,181,0)
+366 ;;=HEART CATHETERIZATIONS^8^21
+367 ;;^UTILITY(U,$J,358.4,182,0)
+368 ;;=CATHETERIZATIONS FOR INT RADIOLOGY^2^21
+369 ;;^UTILITY(U,$J,358.4,183,0)
+370 ;;=OTHER HEART CODES^13^21
+371 ;;^UTILITY(U,$J,358.4,184,0)
+372 ;;=PROSTHETIC ANEURYSM REPAIR^19^21
+373 ;;^UTILITY(U,$J,358.4,185,0)
+374 ;;=DEVICE PROGRAMMING^4^21
+375 ;;^UTILITY(U,$J,358.4,186,0)
+376 ;;=ECHO^5^21
+377 ;;^UTILITY(U,$J,358.4,187,0)
+378 ;;=EKG^6^21
+379 ;;^UTILITY(U,$J,358.4,188,0)
+380 ;;=MEDICATION ADMINISTRATION^9^21
+381 ;;^UTILITY(U,$J,358.4,189,0)
+382 ;;=MEDICATIONS^10^21
+383 ;;^UTILITY(U,$J,358.4,190,0)
+384 ;;=OTHER CARDIAC^12^21
+385 ;;^UTILITY(U,$J,358.4,191,0)
+386 ;;=STRESS TESTS^20^21
+387 ;;^UTILITY(U,$J,358.4,192,0)
+388 ;;=PREVENTIVE COUNSELING^17^21
+389 ;;^UTILITY(U,$J,358.4,193,0)
+390 ;;=MODERATE SEDATION (MS)^11^21
+391 ;;^UTILITY(U,$J,358.4,194,0)
+392 ;;=VENTRICULAR ASSIST DEVICE INSERTION^22^21
+393 ;;^UTILITY(U,$J,358.4,195,0)
+394 ;;=CARDIOVERSION^1^21
+395 ;;^UTILITY(U,$J,358.4,196,0)
+396 ;;=PROLONGED SERVICES^18^21
+397 ;;^UTILITY(U,$J,358.4,197,0)
+398 ;;=NEW PATIENT^2^22
+399 ;;^UTILITY(U,$J,358.4,198,0)
+400 ;;=ESTABLISHED PATIENT^1^22
+401 ;;^UTILITY(U,$J,358.4,199,0)
+402 ;;=CONSULTATIONS^3^22
+403 ;;^UTILITY(U,$J,358.4,200,0)
+404 ;;=MISCELLANEOUS TREATMENT^4^23
+405 ;;^UTILITY(U,$J,358.4,201,0)
+406 ;;=CHIROPRACTIC MANIPULATIVE SERVICES^2^23
+407 ;;^UTILITY(U,$J,358.4,202,0)
+408 ;;=OSTEOPATHIC MANIPULATIVE TREATMENT^5^23
+409 ;;^UTILITY(U,$J,358.4,203,0)
+410 ;;=ACUPUNCTURE^1^23
+411 ;;^UTILITY(U,$J,358.4,204,0)
+412 ;;=EDUCATION FOR SELF MGT^3^23
+413 ;;^UTILITY(U,$J,358.4,205,0)
+414 ;;=EXTREMITIES/JOINTS/MUSCLES^6^24
+415 ;;^UTILITY(U,$J,358.4,206,0)
+416 ;;=HEAD AREA/NERVES^1^24
+417 ;;^UTILITY(U,$J,358.4,207,0)
+418 ;;=CERVICAL^2^24
+419 ;;^UTILITY(U,$J,358.4,208,0)
+420 ;;=THORACIC^3^24
+421 ;;^UTILITY(U,$J,358.4,209,0)
+422 ;;=LUMBAR^4^24
+423 ;;^UTILITY(U,$J,358.4,210,0)
+424 ;;=SACRUM^5^24
+425 ;;^UTILITY(U,$J,358.4,211,0)
+426 ;;=UNSPECIFIED^8^24
+427 ;;^UTILITY(U,$J,358.4,212,0)
+428 ;;=SUICIDE IDEATIONS/ATTEMPTS^7^24
+429 ;;^UTILITY(U,$J,358.4,213,0)
+430 ;;=NEW PATIENT^1^25
+431 ;;^UTILITY(U,$J,358.4,214,0)
+432 ;;=ESTABLISHED PATIENT^2^25
+433 ;;^UTILITY(U,$J,358.4,215,0)
+434 ;;=EDUCATION & TRAINING FOR SELF MGMT^4^25
+435 ;;^UTILITY(U,$J,358.4,216,0)
+436 ;;=MEDICATION ADMIN^7^25
+437 ;;^UTILITY(U,$J,358.4,217,0)
+438 ;;=IMMUNIZATION ADMINISTRATION^5^25
+439 ;;^UTILITY(U,$J,358.4,218,0)
+440 ;;=IMMUNIZATIONS^6^25
+441 ;;^UTILITY(U,$J,358.4,219,0)
+442 ;;=CONTINUOUS GLUCOSE MONITORING^3^25
+443 ;;^UTILITY(U,$J,358.4,220,0)
+444 ;;=ANTICOAGULATION^2^26
+445 ;;^UTILITY(U,$J,358.4,221,0)
+446 ;;=PAIN^6^26
+447 ;;^UTILITY(U,$J,358.4,222,0)
+448 ;;=MENTAL HEALTH^5^26
+449 ;;^UTILITY(U,$J,358.4,223,0)
+450 ;;=ENDOCRINE^4^26
+451 ;;^UTILITY(U,$J,358.4,224,0)
+452 ;;=CARDIOVASCULAR^3^26
+453 ;;^UTILITY(U,$J,358.4,225,0)
+454 ;;=RESPIRATORY^7^26
+455 ;;^UTILITY(U,$J,358.4,226,0)
+456 ;;=OTHER^8^26
+457 ;;^UTILITY(U,$J,358.4,227,0)
+458 ;;=COMMON DIAGNOSIS^1^26
+459 ;;^UTILITY(U,$J,358.4,228,0)
+460 ;;=NEW PATIENT^3^27
+461 ;;^UTILITY(U,$J,358.4,229,0)
+462 ;;=ESTABLISHED PATIENT^1^27
+463 ;;^UTILITY(U,$J,358.4,230,0)
+464 ;;=CONSULTATIONS^2^27
+465 ;;^UTILITY(U,$J,358.4,231,0)
+466 ;;=PREVENTIVE MEDICINE-EST PT^4^27
+467 ;;^UTILITY(U,$J,358.4,232,0)
+468 ;;=PREVENTIVE MEDICINE-NEW PT^5^27
+469 ;;^UTILITY(U,$J,358.4,233,0)
+470 ;;=RISK FACTOR REDUCTION-GRP^6^27
+471 ;;^UTILITY(U,$J,358.4,234,0)
+472 ;;=RISK FACTOR REDUCTION-IND^7^27
+473 ;;^UTILITY(U,$J,358.4,235,0)
+474 ;;=OTHER^3^28
+475 ;;^UTILITY(U,$J,358.4,236,0)
+476 ;;=EDUCATION/TRAINING^1^28
+477 ;;^UTILITY(U,$J,358.4,237,0)
+478 ;;=MEDICAL NUTRITION THERAPY^2^28
+479 ;;^UTILITY(U,$J,358.4,238,0)
+480 ;;=WOUND TREATMENT^5^28
+481 ;;^UTILITY(U,$J,358.4,239,0)
+482 ;;=PROLONGED SERVICES^4^28
+483 ;;^UTILITY(U,$J,358.4,240,0)
+484 ;;=DIABETES^1^29
+485 ;;^UTILITY(U,$J,358.4,241,0)
+486 ;;=SUICIDE IDEATIONS/ATTEMPTS^3^29
+487 ;;^UTILITY(U,$J,358.4,242,0)
+488 ;;=SOCIAL DETERMINANTS OF HEALTH^2^29
+489 ;;^UTILITY(U,$J,358.4,243,0)
+490 ;;=IMMUNIZATION^10^30
+491 ;;^UTILITY(U,$J,358.4,244,0)
+492 ;;=MEDICATION^13^30
+493 ;;^UTILITY(U,$J,358.4,245,0)
+494 ;;=ORTHO/JOINTS^6^30
+495 ;;^UTILITY(U,$J,358.4,246,0)
+496 ;;=RESPIRATORY SYSTEM^14^30
+497 ;;^UTILITY(U,$J,358.4,247,0)
+498 ;;=CRITICAL CARE/PULM/SEDATION^3^30
+499 ;;^UTILITY(U,$J,358.4,248,0)
+500 ;;=GI/GYN^7^30
+501 ;;^UTILITY(U,$J,358.4,249,0)
+502 ;;=NEURO/EYE/ENT^8^30
+503 ;;^UTILITY(U,$J,358.4,250,0)
+504 ;;=LACERATIONS^5^30
+505 ;;^UTILITY(U,$J,358.4,251,0)
+506 ;;=SKIN WOUNDS/BURNS^4^30
+507 ;;^UTILITY(U,$J,358.4,252,0)
+508 ;;=PSYCHIATRY^9^30
+509 ;;^UTILITY(U,$J,358.4,253,0)
+510 ;;=COMMON PROCEDURES^1^30
+511 ;;^UTILITY(U,$J,358.4,254,0)
+512 ;;=INFUSION/INJECTION ADMIN^11^30
+513 ;;^UTILITY(U,$J,358.4,255,0)
+514 ;;=ADDITIONAL VISIT CODES^2^30
+515 ;;^UTILITY(U,$J,358.4,256,0)
+516 ;;=COVID-19 RELATED^12^30
+517 ;;^UTILITY(U,$J,358.4,257,0)
+518 ;;=HEDIS CODE/MISC HCPCS^15^30
+519 ;;^UTILITY(U,$J,358.4,258,0)
+520 ;;=LABS PERFORMED IN ED^16^30
+521 ;;^UTILITY(U,$J,358.4,259,0)
+522 ;;=EMERGENCY DEPT VISIT^1^31
+523 ;;^UTILITY(U,$J,358.4,260,0)
+524 ;;=TRIAGE ONLY (NO MD SEEN)^4^31
+525 ;;^UTILITY(U,$J,358.4,261,0)
+526 ;;=ED OBS 1ST DAY-INIT^3^31
+527 ;;^UTILITY(U,$J,358.4,262,0)
+528 ;;=ED OBS (ADMIT&D/C SAME DAY)^2^31
+529 ;;^UTILITY(U,$J,358.4,263,0)
+530 ;;=ED COMMON DIAGNOSES^1^32
+531 ;;^UTILITY(U,$J,358.4,264,0)
+532 ;;=ADMINISTRATIVE TOPICS^2^32
+533 ;;^UTILITY(U,$J,358.4,265,0)
+534 ;;=CARDIOVASCULAR^3^32
+535 ;;^UTILITY(U,$J,358.4,266,0)
+536 ;;=EAR/NOSE/THROAT^6^32
+537 ;;^UTILITY(U,$J,358.4,267,0)
+538 ;;=ENDO/RENAL/ELECTROLYTES^5^32
+539 ;;^UTILITY(U,$J,358.4,268,0)
+540 ;;=EYE^7^32
+541 ;;^UTILITY(U,$J,358.4,269,0)
+542 ;;=GI/ABDOMEN^8^32
+543 ;;^UTILITY(U,$J,358.4,270,0)
+544 ;;=PSYCHIATRY^17^32
+545 ;;^UTILITY(U,$J,358.4,271,0)
+546 ;;=LACERATION(S)^16^32
+547 ;;^UTILITY(U,$J,358.4,272,0)
+548 ;;=PULMONARY^18^32
+549 ;;^UTILITY(U,$J,358.4,273,0)
+550 ;;=GU/RECTAL^9^32
+551 ;;^UTILITY(U,$J,358.4,274,0)
+552 ;;=HEME/ONC/VASCULAR^10^32
+553 ;;^UTILITY(U,$J,358.4,275,0)
+554 ;;=INFECTIOUS DISEASE^11^32
+555 ;;^UTILITY(U,$J,358.4,276,0)
+556 ;;=MUSCULOSKELETAL/MISC^14^32
+557 ;;^UTILITY(U,$J,358.4,277,0)
+558 ;;=NEUROLOGY^15^32
+559 ;;^UTILITY(U,$J,358.4,278,0)
+560 ;;=SKIN^19^32
+561 ;;^UTILITY(U,$J,358.4,279,0)
+562 ;;=MUSCULOSKELETAL-LE^12^32
+563 ;;^UTILITY(U,$J,358.4,280,0)
+564 ;;=MUSCULOSKELETAL-UE^13^32
+565 ;;^UTILITY(U,$J,358.4,281,0)
+566 ;;=SUICIDE IDEATIONS/ATTEMPTS^21^32
+567 ;;^UTILITY(U,$J,358.4,282,0)
+568 ;;=E-CIG/VAPE LUNG INJURY (EVAL)^4^32
+569 ;;^UTILITY(U,$J,358.4,283,0)
+570 ;;=FALLS^22^32
+571 ;;^UTILITY(U,$J,358.4,284,0)
+572 ;;=VEHICLE ACCIDENTS^24^32
+573 ;;^UTILITY(U,$J,358.4,285,0)
+574 ;;=EXTERNAL CAUSES^26^32
+575 ;;^UTILITY(U,$J,358.4,286,0)
+576 ;;=PAIN^20^32
+577 ;;^UTILITY(U,$J,358.4,287,0)
+578 ;;=BITES-HUMAN/ANIMAL/INSECT^23^32
+579 ;;^UTILITY(U,$J,358.4,288,0)
+580 ;;=SUSPECTED COND R/O AFTER OBS^25^32
+581 ;;^UTILITY(U,$J,358.4,289,0)
+582 ;;=NEW PATIENT^2^33
+583 ;;^UTILITY(U,$J,358.4,290,0)
+584 ;;=ESTABLISHED PATIENT^1^33
+585 ;;^UTILITY(U,$J,358.4,291,0)
+586 ;;=CONSULTATIONS^3^33
+587 ;;^UTILITY(U,$J,358.4,292,0)
+588 ;;=ENDOCRINE DX^1^34
+589 ;;^UTILITY(U,$J,358.4,293,0)
+590 ;;=SUICIDE IDEATIONS/ATTEMPTS^3^34
+591 ;;^UTILITY(U,$J,358.4,294,0)
+592 ;;=SOCIAL DETERMINANTS OF HEALTH^2^34
+593 ;;^UTILITY(U,$J,358.4,295,0)
+594 ;;=BIOPSIES^1^35
+595 ;;^UTILITY(U,$J,358.4,296,0)
+596 ;;=INJECTIONS & INFUSIONS^2^35
+597 ;;^UTILITY(U,$J,358.4,297,0)
+598 ;;=OTHER^4^35
+599 ;;^UTILITY(U,$J,358.4,298,0)
+600 ;;=PROLONGED CLINICAL STAFF SERVICES^5^35
+601 ;;^UTILITY(U,$J,358.4,299,0)
+602 ;;=LAB TESTS^3^35
+603 ;;^UTILITY(U,$J,358.4,300,0)
+604 ;;=TEST - CATARACT / COLOR^4^36
+605 ;;^UTILITY(U,$J,358.4,301,0)
+606 ;;=IMAGING / PHOTOS^2^36
+607 ;;^UTILITY(U,$J,358.4,302,0)
+608 ;;=TEST - GLAUCOMA^3^36
+609 ;;^UTILITY(U,$J,358.4,303,0)
+610 ;;=TEST - OTHER^5^36
+611 ;;^UTILITY(U,$J,358.4,304,0)
+612 ;;=REFRACT / GLASSES / CL^1^36
+613 ;;^UTILITY(U,$J,358.4,305,0)
+614 ;;=EEF Version 2022 July^6^36
+615 ;;^UTILITY(U,$J,358.4,306,0)
+616 ;;=LOW VISION / BLINDNESS^21^37
+617 ;;^UTILITY(U,$J,358.4,307,0)
+618 ;;=RETINA - VASCULAR^12^37
+619 ;;^UTILITY(U,$J,358.4,308,0)
+620 ;;=EYELIDS / LASHES^2^37
+621 ;;^UTILITY(U,$J,358.4,309,0)
+622 ;;=NEURO / STRABISMUS^18^37
+623 ;;^UTILITY(U,$J,358.4,310,0)
+624 ;;=ORBIT - PLASTICS^20^37
+625 ;;^UTILITY(U,$J,358.4,311,0)
+626 ;;=VITREOUS^17^37
+627 ;;^UTILITY(U,$J,358.4,312,0)
+628 ;;=ORBIT - TRAUMA^19^37
+629 ;;^UTILITY(U,$J,358.4,313,0)
+630 ;;=LACRIMAL / NLD / NEOPLASMS^3^37
+631 ;;^UTILITY(U,$J,358.4,314,0)
+632 ;;=MOST FREQUENT^1^37
+633 ;;^UTILITY(U,$J,358.4,315,0)
+634 ;;=CONJUNCTIVA / SCLERA^4^37
+635 ;;^UTILITY(U,$J,358.4,316,0)
+636 ;;=CORNEA / ULCER^5^37
+637 ;;^UTILITY(U,$J,358.4,317,0)
+638 ;;=LENS / CATARACT / POSTOP^6^37
+639 ;;^UTILITY(U,$J,358.4,318,0)
+640 ;;=IRIS / UVEITIS^7^37
+641 ;;^UTILITY(U,$J,358.4,319,0)
+642 ;;=GLAUCOMA - OPEN ANGLE^8^37
+643 ;;^UTILITY(U,$J,358.4,320,0)
+644 ;;=GLAUCOMA - CLOSED ANGLE^9^37
+645 ;;^UTILITY(U,$J,358.4,321,0)
+646 ;;=GLAUCOMA - SECONDARY^10^37
+647 ;;^UTILITY(U,$J,358.4,322,0)
+648 ;;=RETINA - CHOROID / TUMORS / INFLAM^14^37
+649 ;;^UTILITY(U,$J,358.4,323,0)
+650 ;;=RETINA - TEAR / PERIPH / DEGENERATION^15^37
+651 ;;^UTILITY(U,$J,358.4,324,0)
+652 ;;=RETINA - MACULA^11^37
+653 ;;^UTILITY(U,$J,358.4,325,0)
+654 ;;=SUICIDE IDEATIONS/ATTEMPTS^23^37
